PER
Click for more information
3.70% 8.4¢ percheron therapeutics limited

For General Information, page-42

  1. RYNZN
    3,056 Posts.
    lightbulb Created with Sketch. 495
    clock Created with Sketch.
    21/04/22
    13:42
    Post #: 60951791
    Aside from Murdoch new indications (which wont do much) I think first patient dosed would. Covid positive results might. Third quarter dystrophin results would but that's too far away. Financing the remaining 16m would but perhaps we're pushing as far ahead without it. which brings me back to first patient dosed.

    or,
    Takeover offer at $5B
    ANP Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.003(3.70%) 		Mkt cap ! $75.73M
Open High Low Value Volume
8.1¢ 8.4¢ 8.1¢ $79.19K 960.1K

Buyers (Bids)

No. Vol. Price($)
1 100200 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 114242 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.